Involvement of K v1.3 and p38 MAPK signaling in HIV-1 glycoprotein 120-induced microglia neurotoxicity

J. Liu, C. Xu, L. Chen, P. Xu, Huangui Xiong

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Inflammatory responses mediated by activated microglia play a pivotal role in the pathogenesis of human immunodeficiency virus type 1 (HIV-1)-associated neurocognitive disorders. Studies on identification of specific targets to control microglia activation and resultant neurotoxic activity are imperative. Increasing evidence indicate that voltage-gated K + (K v) channels are involved in the regulation of microglia functionality. In this study, we investigated K v1.3 channels in the regulation of neurotoxic activity mediated by HIV-1 glycoprotein 120 (gp120)-stimulated rat microglia. Our results showed treatment of microglia with gp120 increased the expression levels of K v1.3 mRNA and protein. In parallel, whole-cell patch-clamp studies revealed that gp120 enhanced microglia K v1.3 current, which was blocked by margatoxin, a K v1.3 blocker. The association of gp120 enhancement of K v1.3 current with microglia neurotoxicity was demonstrated by experimental results that blocking microglia K v1.3 attenuated gp120-associated microglia production of neurotoxins and neurotoxicity. Knockdown of K v1.3 gene by transfection of microglia with K v1.3-siRNA abrogated gp120-associated microglia neurotoxic activity. Further investigation unraveled an involvement of p38 MAPK in gp120 enhancement of microglia K v1.3 expression and resultant neurotoxic activity. These results suggest not only a role K v1.3 may have in gp120-associated microglia neurotoxic activity, but also a potential target for the development of therapeutic strategies.

Original languageEnglish (US)
Article numbere254
JournalCell Death and Disease
Volume3
Issue number1
DOIs
StatePublished - Jan 1 2012

Fingerprint

Microglia
p38 Mitogen-Activated Protein Kinases
HIV-1
Glycoproteins
Neurotoxins
Small Interfering RNA
Transfection

Keywords

  • Cytokines
  • HIV-1gp120
  • Microglia
  • Neurotoxicity
  • Voltage-gated K channels

ASJC Scopus subject areas

  • Immunology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Cancer Research

Cite this

Involvement of K v1.3 and p38 MAPK signaling in HIV-1 glycoprotein 120-induced microglia neurotoxicity. / Liu, J.; Xu, C.; Chen, L.; Xu, P.; Xiong, Huangui.

In: Cell Death and Disease, Vol. 3, No. 1, e254, 01.01.2012.

Research output: Contribution to journalArticle

@article{1167e38e3eee40bfac32e906a67a2b5d,
title = "Involvement of K v1.3 and p38 MAPK signaling in HIV-1 glycoprotein 120-induced microglia neurotoxicity",
abstract = "Inflammatory responses mediated by activated microglia play a pivotal role in the pathogenesis of human immunodeficiency virus type 1 (HIV-1)-associated neurocognitive disorders. Studies on identification of specific targets to control microglia activation and resultant neurotoxic activity are imperative. Increasing evidence indicate that voltage-gated K + (K v) channels are involved in the regulation of microglia functionality. In this study, we investigated K v1.3 channels in the regulation of neurotoxic activity mediated by HIV-1 glycoprotein 120 (gp120)-stimulated rat microglia. Our results showed treatment of microglia with gp120 increased the expression levels of K v1.3 mRNA and protein. In parallel, whole-cell patch-clamp studies revealed that gp120 enhanced microglia K v1.3 current, which was blocked by margatoxin, a K v1.3 blocker. The association of gp120 enhancement of K v1.3 current with microglia neurotoxicity was demonstrated by experimental results that blocking microglia K v1.3 attenuated gp120-associated microglia production of neurotoxins and neurotoxicity. Knockdown of K v1.3 gene by transfection of microglia with K v1.3-siRNA abrogated gp120-associated microglia neurotoxic activity. Further investigation unraveled an involvement of p38 MAPK in gp120 enhancement of microglia K v1.3 expression and resultant neurotoxic activity. These results suggest not only a role K v1.3 may have in gp120-associated microglia neurotoxic activity, but also a potential target for the development of therapeutic strategies.",
keywords = "Cytokines, HIV-1gp120, Microglia, Neurotoxicity, Voltage-gated K channels",
author = "J. Liu and C. Xu and L. Chen and P. Xu and Huangui Xiong",
year = "2012",
month = "1",
day = "1",
doi = "10.1038/cddis.2011.140",
language = "English (US)",
volume = "3",
journal = "Cell Death and Disease",
issn = "2041-4889",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Involvement of K v1.3 and p38 MAPK signaling in HIV-1 glycoprotein 120-induced microglia neurotoxicity

AU - Liu, J.

AU - Xu, C.

AU - Chen, L.

AU - Xu, P.

AU - Xiong, Huangui

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Inflammatory responses mediated by activated microglia play a pivotal role in the pathogenesis of human immunodeficiency virus type 1 (HIV-1)-associated neurocognitive disorders. Studies on identification of specific targets to control microglia activation and resultant neurotoxic activity are imperative. Increasing evidence indicate that voltage-gated K + (K v) channels are involved in the regulation of microglia functionality. In this study, we investigated K v1.3 channels in the regulation of neurotoxic activity mediated by HIV-1 glycoprotein 120 (gp120)-stimulated rat microglia. Our results showed treatment of microglia with gp120 increased the expression levels of K v1.3 mRNA and protein. In parallel, whole-cell patch-clamp studies revealed that gp120 enhanced microglia K v1.3 current, which was blocked by margatoxin, a K v1.3 blocker. The association of gp120 enhancement of K v1.3 current with microglia neurotoxicity was demonstrated by experimental results that blocking microglia K v1.3 attenuated gp120-associated microglia production of neurotoxins and neurotoxicity. Knockdown of K v1.3 gene by transfection of microglia with K v1.3-siRNA abrogated gp120-associated microglia neurotoxic activity. Further investigation unraveled an involvement of p38 MAPK in gp120 enhancement of microglia K v1.3 expression and resultant neurotoxic activity. These results suggest not only a role K v1.3 may have in gp120-associated microglia neurotoxic activity, but also a potential target for the development of therapeutic strategies.

AB - Inflammatory responses mediated by activated microglia play a pivotal role in the pathogenesis of human immunodeficiency virus type 1 (HIV-1)-associated neurocognitive disorders. Studies on identification of specific targets to control microglia activation and resultant neurotoxic activity are imperative. Increasing evidence indicate that voltage-gated K + (K v) channels are involved in the regulation of microglia functionality. In this study, we investigated K v1.3 channels in the regulation of neurotoxic activity mediated by HIV-1 glycoprotein 120 (gp120)-stimulated rat microglia. Our results showed treatment of microglia with gp120 increased the expression levels of K v1.3 mRNA and protein. In parallel, whole-cell patch-clamp studies revealed that gp120 enhanced microglia K v1.3 current, which was blocked by margatoxin, a K v1.3 blocker. The association of gp120 enhancement of K v1.3 current with microglia neurotoxicity was demonstrated by experimental results that blocking microglia K v1.3 attenuated gp120-associated microglia production of neurotoxins and neurotoxicity. Knockdown of K v1.3 gene by transfection of microglia with K v1.3-siRNA abrogated gp120-associated microglia neurotoxic activity. Further investigation unraveled an involvement of p38 MAPK in gp120 enhancement of microglia K v1.3 expression and resultant neurotoxic activity. These results suggest not only a role K v1.3 may have in gp120-associated microglia neurotoxic activity, but also a potential target for the development of therapeutic strategies.

KW - Cytokines

KW - HIV-1gp120

KW - Microglia

KW - Neurotoxicity

KW - Voltage-gated K channels

UR - http://www.scopus.com/inward/record.url?scp=84863118211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863118211&partnerID=8YFLogxK

U2 - 10.1038/cddis.2011.140

DO - 10.1038/cddis.2011.140

M3 - Article

C2 - 22258405

AN - SCOPUS:84863118211

VL - 3

JO - Cell Death and Disease

JF - Cell Death and Disease

SN - 2041-4889

IS - 1

M1 - e254

ER -